Price is getting capped. The big order at 10.5c is probably one of our insto holders. If the options aren’t in the money at the end of 2023 they’ll need to be a raise soon after I’d imagine.
Yes the global market is bearish so who wants to put $s into a $20m MC biotech?
Early efficacy on the ACCENT trial is our catalyst for a rerate.
Price is getting capped. The big order at 10.5c is probably one...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $39.84M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 14.5¢ | $47.81K | 319.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 161129 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |